Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.29M | 6.93M | 7.66M | 6.81M | 9.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.29M | 6.93M | 7.66M | 6.81M | 9.58M |
| Cost of Revenue | 3.68M | 2.75M | 3.36M | 3.17M | 3.81M |
| Gross Profit | 5.61M | 4.18M | 4.31M | 3.65M | 5.76M |
| SG&A Expenses | 5.51M | 5.87M | 6.44M | 5.57M | 5.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.14M | -- | -- | -- | -- |
| Total Operating Expenses | 17.38M | 8.79M | 9.89M | 8.83M | 9.59M |
| Operating Income | 1.21M | -1.86M | -2.22M | -2.02M | -17.00K |
| Income Before Tax | 70.00K | -1.62M | -2.49M | -2.43M | -4.73M |
| Income Tax Expenses | 12.00K | -- | -- | -- | -170.00K |
| Earnings from Continuing Operations | 58.00K | -1.62M | -2.49M | -2.43M | -4.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.00K | -1.62M | -2.49M | -2.43M | -4.56M |
| EBIT | 1.21M | -1.86M | -2.22M | -2.02M | -17.00K |
| EBITDA | 2.85M | -993.00K | -1.01M | -795.00K | 1.21M |
| EPS Basic | 0.01 | -0.36 | -0.60 | -0.58 | -1.09 |
| Normalized Basic EPS | 0.04 | -0.32 | -0.37 | -0.36 | -0.07 |
| EPS Diluted | 0.02 | -0.36 | -0.60 | -0.58 | -1.09 |
| Normalized Diluted EPS | 0.04 | -0.32 | -0.37 | -0.36 | -0.07 |
| Average Basic Shares Outstanding | 5.78M | 4.48M | 4.17M | 4.17M | 4.17M |
| Average Diluted Shares Outstanding | 5.78M | 4.48M | 4.17M | 4.17M | 4.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |